GSK plc
GSK
#210
Rank
โ‚ฌ85.89 B
Marketcap
42,50ย โ‚ฌ
Share price
1.12%
Change (1 day)
30.66%
Change (1 year)

Revenue for GSK plc (GSK)

Revenue in 2025 (TTM): โ‚ฌ37.85 Billion

According to GSK plc's latest financial reports the company's current revenue (TTM ) is โ‚ฌ35.52 Billion. In 2024 the company made a revenue of โ‚ฌ38.61 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ34.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GSK plc from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ37.85 B-1.95%
2024 โ‚ฌ38.61 B12.62%
2023 โ‚ฌ34.28 B3.56%
2022 โ‚ฌ33.10 B-6.47%
2021 โ‚ฌ35.39 B-0.61%
2020 โ‚ฌ35.61 B-7.42%
2019 โ‚ฌ38.46 B7.99%
2018 โ‚ฌ35.62 B7.89%
2017 โ‚ฌ33.01 B-5.61%
2016 โ‚ฌ34.97 B5.78%
2015 โ‚ฌ33.06 B6.8%
2014 โ‚ฌ30.96 B2.23%
2013 โ‚ฌ30.28 B-5.24%
2012 โ‚ฌ31.96 B-4.1%
2011 โ‚ฌ33.32 B1.4%
2010 โ‚ฌ32.87 B5.24%
2009 โ‚ฌ31.23 B0.03%
2008 โ‚ฌ31.22 B0.33%
2007 โ‚ฌ31.12 B-4.24%
2006 โ‚ฌ32.50 B-0.18%
2005 โ‚ฌ32.55 B17.24%
2004 โ‚ฌ27.77 B-2.25%
2003 โ‚ฌ28.41 B-8.62%
2002 โ‚ฌ31.08 B-7.05%
2001 โ‚ฌ33.44 B15.08%
2000 โ‚ฌ29.06 B108.91%
1999 โ‚ฌ13.91 B23.28%
1998 โ‚ฌ11.28 B3.3%
1997 โ‚ฌ10.92 B-19.73%
1996 โ‚ฌ13.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ47.29 B 33.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ52.67 B 48.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ39.86 B 12.21%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ53.88 B 51.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ48.76 B 37.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.07 B-60.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.27 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA